 | • レポートコード：QFJ1-4941 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、タンパク質＆抗体＆核酸デリバリー技術の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（HEPtune®技術、Intravail®技術、RapidMist™、TheraKine技術、Arestat™技術、DelSiTech™シリカマトリックス、ImSus®技術、PLEX™技術、ENHANZE®技術）、用途別市場規模（タンパク質送達、核酸送達、送達抗体）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・タンパク質＆抗体＆核酸デリバリー技術の市場動向 ・企業の競争状況、市場シェア ・タンパク質＆抗体＆核酸デリバリー技術の種類別市場規模と予測2016-2027（HEPtune®技術、Intravail®技術、RapidMist™、TheraKine技術、Arestat™技術、DelSiTech™シリカマトリックス、ImSus®技術、PLEX™技術、ENHANZE®技術） ・タンパク質＆抗体＆核酸デリバリー技術の用途別市場規模と予測2016-2027（タンパク質送達、核酸送達、送達抗体） ・タンパク質＆抗体＆核酸デリバリー技術の北米市場規模2016-2027（アメリカ、カナダ） ・タンパク質＆抗体＆核酸デリバリー技術の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・タンパク質＆抗体＆核酸デリバリー技術のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・タンパク質＆抗体＆核酸デリバリー技術の中南米市場規模2016-2027（メキシコ、ブラジル） ・タンパク質＆抗体＆核酸デリバリー技術の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Aphios、Arbutus Biopharma、Camurus、ConjuChem、InnoCore Pharmaceuticals、LATITUDE Pharmaceuticals） ・結論 |
Novel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids
Given their high target specificity and limited toxicity compared to small molecule drugs, biotherapeutics have revolutionized treatment paradigms in a myriad of clinical conditions, including metabolic disorders, cancer, neurological disorders and autoimmune diseases. And apply a variety of new technologies.
Market Analysis and Insights: Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market
The global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids market.
Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Scope and Market Size
Technologies for Delivery of Proteins, Antibodies and Nucleic Acids market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
HEPtune® Technology
Intravail® Technology
RapidMist™
TheraKine Technology
Arestat™ Technology
DelSiTech™ Silica Matrix
ImSus® Technology
PLEX™ Technology
ENHANZE® Technology
Segment by Application
Delivery of Protein
Delivery of Nucleic Acids
Delivery Antibody
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Aphios
Arbutus Biopharma
Camurus
ConjuChem
InnoCore Pharmaceuticals
LATITUDE Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 HEPtune® Technology
1.2.3 Intravail® Technology
1.2.4 RapidMist™
1.2.5 TheraKine Technology
1.2.6 Arestat™ Technology
1.2.7 DelSiTech™ Silica Matrix
1.2.8 ImSus® Technology
1.2.9 PLEX™ Technology
1.2.10 ENHANZE® Technology
1.3 Market by Application
1.3.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Delivery of Protein
1.3.3 Delivery of Nucleic Acids
1.3.4 Delivery Antibody
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Perspective (2016-2027)
2.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Growth Trends by Regions
2.2.1 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Historic Market Share by Regions (2016-2021)
2.2.3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Forecasted Market Size by Regions (2022-2027)
2.3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Industry Dynamic
2.3.1 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Trends
2.3.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Drivers
2.3.3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Challenges
2.3.4 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players by Revenue
3.1.1 Global Top Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players by Revenue (2016-2021)
3.1.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Players (2016-2021)
3.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue
3.4 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Concentration Ratio
3.4.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in 2020
3.5 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players Head office and Area Served
3.6 Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product Solution and Service
3.7 Date of Enter into Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Breakdown Data by Type
4.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Historic Market Size by Type (2016-2021)
4.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Forecasted Market Size by Type (2022-2027)
5 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Breakdown Data by Application
5.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Historic Market Size by Application (2016-2021)
5.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2016-2027)
6.2 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type
6.2.1 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2021)
6.2.2 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2022-2027)
6.2.3 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2027)
6.3 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application
6.3.1 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2021)
6.3.2 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2022-2027)
6.3.3 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2027)
6.4 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country
6.4.1 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2016-2021)
6.4.2 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2016-2027)
7.2 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type
7.2.1 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2021)
7.2.2 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2022-2027)
7.2.3 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2027)
7.3 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application
7.3.1 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2021)
7.3.2 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2022-2027)
7.3.3 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2027)
7.4 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country
7.4.1 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2016-2021)
7.4.2 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2016-2027)
8.2 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type
8.2.1 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2027)
8.3 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application
8.3.1 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2027)
8.4 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Region
8.4.1 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2016-2027)
9.2 Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type
9.2.1 Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2021)
9.2.2 Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2022-2027)
9.2.3 Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2027)
9.3 Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application
9.3.1 Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2021)
9.3.2 Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2022-2027)
9.3.3 Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2027)
9.4 Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country
9.4.1 Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2016-2021)
9.4.2 Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2016-2027)
10.2 Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type
10.2.1 Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2027)
10.3 Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application
10.3.1 Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2027)
10.4 Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country
10.4.1 Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Aphios
11.1.1 Aphios Company Details
11.1.2 Aphios Business Overview
11.1.3 Aphios Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
11.1.4 Aphios Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021)
11.1.5 Aphios Recent Development
11.2 Arbutus Biopharma
11.2.1 Arbutus Biopharma Company Details
11.2.2 Arbutus Biopharma Business Overview
11.2.3 Arbutus Biopharma Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
11.2.4 Arbutus Biopharma Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021)
11.2.5 Arbutus Biopharma Recent Development
11.3 Camurus
11.3.1 Camurus Company Details
11.3.2 Camurus Business Overview
11.3.3 Camurus Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
11.3.4 Camurus Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021)
11.3.5 Camurus Recent Development
11.4 ConjuChem
11.4.1 ConjuChem Company Details
11.4.2 ConjuChem Business Overview
11.4.3 ConjuChem Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
11.4.4 ConjuChem Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021)
11.4.5 ConjuChem Recent Development
11.5 InnoCore Pharmaceuticals
11.5.1 InnoCore Pharmaceuticals Company Details
11.5.2 InnoCore Pharmaceuticals Business Overview
11.5.3 InnoCore Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
11.5.4 InnoCore Pharmaceuticals Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021)
11.5.5 InnoCore Pharmaceuticals Recent Development
11.6 LATITUDE Pharmaceuticals
11.6.1 LATITUDE Pharmaceuticals Company Details
11.6.2 LATITUDE Pharmaceuticals Business Overview
11.6.3 LATITUDE Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
11.6.4 LATITUDE Pharmaceuticals Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021)
11.6.5 LATITUDE Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of HEPtune® Technology
Table 3. Key Players of Intravail® Technology
Table 4. Key Players of RapidMist™
Table 5. Key Players of TheraKine Technology
Table 6. Key Players of Arestat™ Technology
Table 7. Key Players of DelSiTech™ Silica Matrix
Table 8. Key Players of ImSus® Technology
Table 9. Key Players of PLEX™ Technology
Table 10. Key Players of ENHANZE® Technology
Table 11. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 13. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Regions (2016-2021) & (US$ Million)
Table 14. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Regions (2016-2021)
Table 15. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 16. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Regions (2022-2027)
Table 17. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Trends
Table 18. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Drivers
Table 19. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Challenges
Table 20. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Restraints
Table 21. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Players (2016-2021) & (US$ Million)
Table 22. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Players (2016-2021)
Table 23. Global Top Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids as of 2020)
Table 24. Ranking of Global Top Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Companies by Revenue (US$ Million) in 2020
Table 25. Global 5 Largest Players Market Share by Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (CR5 and HHI) & (2016-2021)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product Solution and Service
Table 28. Date of Enter into Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2021) (US$ Million)
Table 31. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Type (2016-2021)
Table 32. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 33. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 34. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Share by Application (2016-2021) & (US$ Million)
Table 35. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Application (2016-2021)
Table 36. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 37. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 38. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2021) (US$ Million)
Table 39. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2022-2027) & (US$ Million)
Table 40. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2021) (US$ Million)
Table 41. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2022-2027) & (US$ Million)
Table 42. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2016-2021) & (US$ Million)
Table 43. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2022-2027) & (US$ Million)
Table 44. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2021) (US$ Million)
Table 45. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2022-2027) & (US$ Million)
Table 46. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2021) (US$ Million)
Table 47. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2022-2027) & (US$ Million)
Table 48. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2016-2021) & (US$ Million)
Table 49. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2021) (US$ Million)
Table 51. Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2021) (US$ Million)
Table 53. Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2022-2027) & (US$ Million)
Table 54. Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Region (2016-2021) & (US$ Million)
Table 55. Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Region (2022-2027) & (US$ Million)
Table 56. Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2021) (US$ Million)
Table 57. Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2022-2027) & (US$ Million)
Table 58. Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2021) (US$ Million)
Table 59. Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2022-2027) & (US$ Million)
Table 60. Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2016-2021) & (US$ Million)
Table 61. Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2021) (US$ Million)
Table 63. Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2021) (US$ Million)
Table 65. Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2022-2027) & (US$ Million)
Table 66. Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2016-2021) & (US$ Million)
Table 67. Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2022-2027) & (US$ Million)
Table 68. Aphios Company Details
Table 69. Aphios Business Overview
Table 70. Aphios Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product
Table 71. Aphios Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021) & (US$ Million)
Table 72. Aphios Recent Development
Table 73. Arbutus Biopharma Company Details
Table 74. Arbutus Biopharma Business Overview
Table 75. Arbutus Biopharma Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product
Table 76. Arbutus Biopharma Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021) & (US$ Million)
Table 77. Arbutus Biopharma Recent Development
Table 78. Camurus Company Details
Table 79. Camurus Business Overview
Table 80. Camurus Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product
Table 81. Camurus Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021) & (US$ Million)
Table 82. Camurus Recent Development
Table 83. ConjuChem Company Details
Table 84. ConjuChem Business Overview
Table 85. ConjuChem Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product
Table 86. ConjuChem Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021) & (US$ Million)
Table 87. ConjuChem Recent Development
Table 88. InnoCore Pharmaceuticals Company Details
Table 89. InnoCore Pharmaceuticals Business Overview
Table 90. InnoCore Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product
Table 91. InnoCore Pharmaceuticals Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021) & (US$ Million)
Table 92. InnoCore Pharmaceuticals Recent Development
Table 93. LATITUDE Pharmaceuticals Company Details
Table 94. LATITUDE Pharmaceuticals Business Overview
Table 95. LATITUDE Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product
Table 96. LATITUDE Pharmaceuticals Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021) & (US$ Million)
Table 97. LATITUDE Pharmaceuticals Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type: 2020 VS 2027
Figure 2. HEPtune® Technology Features
Figure 3. Intravail® Technology Features
Figure 4. RapidMist™ Features
Figure 5. TheraKine Technology Features
Figure 6. Arestat™ Technology Features
Figure 7. DelSiTech™ Silica Matrix Features
Figure 8. ImSus® Technology Features
Figure 9. PLEX™ Technology Features
Figure 10. ENHANZE® Technology Features
Figure 11. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application: 2020 VS 2027
Figure 12. Delivery of Protein Case Studies
Figure 13. Delivery of Nucleic Acids Case Studies
Figure 14. Delivery Antibody Case Studies
Figure 15. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Report Years Considered
Figure 16. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Regions: 2020 VS 2027
Figure 19. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Regions (2022-2027)
Figure 20. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Players in 2020
Figure 21. Global Top Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in 2020
Figure 23. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Type (2016-2021)
Figure 24. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Type (2022-2027)
Figure 25. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2016-2027)
Figure 27. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2016-2027)
Figure 28. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Country (2016-2027)
Figure 29. United States Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2016-2027)
Figure 33. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2016-2027)
Figure 34. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Country (2016-2027)
Figure 35. Germany Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Region (2016-2027)
Figure 45. China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2016-2027)
Figure 53. Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2016-2027)
Figure 54. Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Country (2016-2027)
Figure 55. Mexico Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Country (2016-2027)
Figure 61. Turkey Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Aphios Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021)
Figure 65. Arbutus Biopharma Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021)
Figure 66. Camurus Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021)
Figure 67. ConjuChem Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021)
Figure 68. InnoCore Pharmaceuticals Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021)
Figure 69. LATITUDE Pharmaceuticals Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界のドラッグデリバリーアクロス血液脳関門市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drug Delivery Across Blood Brain Barrier Market The global Drug Delivery Across Blood Brain Barrier market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…- 世界の遺伝子導入技術市場規模・現状・予測（2021年-2027年） Gene delivery uses physical, chemical, or viral means to introduce genetic material into cells, thereby amplifying or enhancing their natural functions and harnessing their full therapeutic potential. These techniques use relatively aggressive means to disrupt the cell membrane (from electrical curr…
- 世界のコンテンツデリバリネットワーク（CDN）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Content Delivery Network（CDN） Market The global Content Delivery Network（CDN） market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integ…
- 世界のタンパク質送達市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Protein Delivery Market The global Protein Delivery market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a b…
- 世界の小分子ドラッグデリバリー市場規模・現状・予測（2021年-2027年） The small molecules drugs are able to enter cells easily because of its low molecular weight. These molecules are better than monoclonal antibodies and other large molecule drugs due to their size, easy convertibility to oral form and cost affectivity. The discovery of novel small molecule entities …